NCT04851379

Brief Summary

Objective : To explore the diagnostic contribution of the 18F-FDG-PET/CT in a population of patients with classical fever of unknown origin (FUO), to precise its place in the diagnostic decision tree in a real-life setting and to identify factors associated with a diagnostic 18F-FDG-PET/CT. Methods: All adult patients (age≥18 years) with a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017 were included. True positive 18F-FDG-PET/CT which evidenced a specific disease causing FUO were considered to be contributive.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 8, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2021

Completed
Last Updated

April 20, 2021

Status Verified

April 1, 2021

Enrollment Period

3 months

First QC Date

April 13, 2021

Last Update Submit

April 15, 2021

Conditions

Keywords

Fever of Unknown Origin18F-FDG-PET/CT

Outcome Measures

Primary Outcomes (1)

  • the diagnostic contribution of the 18F-FDG-PET/CT

    the diagnostic contribution of the 18F-FDG-PET/CT in a population of patients with classical FUO.

    day 1

Secondary Outcomes (2)

  • 18F-FDG-PET/CT place in the diagnostic decision tree in a real-life setting

    day 1

  • factors associated with a diagnostic 18F-FDG-PET/CT.

    day 1

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This retrospective study included all adult patients (age≥18 years) with a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017.

You may qualify if:

  • age≥18 years
  • a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT

You may not qualify if:

  • refusal to participate-

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital of Montpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Fever of Unknown Origin

Condition Hierarchy (Ancestors)

FeverBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Camille ROUBILLE, MCUPH

    UH MONTPELLIER

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 20, 2021

Study Start

December 8, 2020

Primary Completion

March 1, 2021

Study Completion

April 1, 2021

Last Updated

April 20, 2021

Record last verified: 2021-04

Locations